Vifor Pharma's goal is to be a global leader in iron deficiency, nephrology and cardio-renal therapies and strives to help patients around the world with severe and chronic diseases to lead better, healthier lives.
www.viforpharma.com AMOUNT: 33.000 Euros
Vifor Pharma supports the Gastro Update Europe 2020 as Gold Partner.
Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in our distinguished history in Japan since in 1781.
www.takeda.com AMOUNT: 10.000 Euros
Takeda supports the Gastro Update Europe 2020 as Partner.
Founded in 1906, Norgine is a leading European specialist pharmaceutical company with a strong global network of partnerships.
www.norgine.com This enables Norgine to acquire, develop and commercialise innovative products that make a real difference to the lives of patients around the world.
AMOUNT: 6.000 Euros
Norgine supports the Gastro Update Europe 2020 as Partner.
Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.
www.bostonscientific.com AMOUNT: 5.000 Euros
Boston Scientific supports the Gastro Update Europe 2020 as Partner.
